CO8 Ponatinib vs Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Matching Adjusted Indirect Comparison
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.089
https://www.valueinhealthjournal.com/article/S1098-3015(22)02293-8/fulltext
Title :
CO8 Ponatinib vs Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Matching Adjusted Indirect Comparison
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02293-8&doi=10.1016/j.jval.2022.09.089
First page :
Section Title :
Open access? :
No
Section Order :
10414